|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:MED4-HTR2A (FusionGDB2 ID:HG29079TG3356) |
Fusion Gene Summary for MED4-HTR2A |
Fusion gene summary |
Fusion gene information | Fusion gene name: MED4-HTR2A | Fusion gene ID: hg29079tg3356 | Hgene | Tgene | Gene symbol | MED4 | HTR2A | Gene ID | 29079 | 3356 |
Gene name | mediator complex subunit 4 | 5-hydroxytryptamine receptor 2A | |
Synonyms | ARC36|DRIP36|HSPC126|TRAP36|VDRIP | 5-HT2A|HTR2 | |
Cytomap | ('MED4')('HTR2A') 13q14.2 | 13q14.2 | |
Type of gene | protein-coding | protein-coding | |
Description | mediator of RNA polymerase II transcription subunit 4TRAP/SMCC/PC2 subunit p36activator-recruited cofactor 36 kDa componentmediator, 34-kD subunit, homologvitamin D receptor-interacting protein, 36-kDvitamin D3 receptor-interacting protein complex 36 | 5-hydroxytryptamine receptor 2A5-HT2 receptor5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledserotonin 5-HT-2A receptor | |
Modification date | 20200313 | 20200315 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000495013, ENST00000258648, ENST00000378586, | ||
Fusion gene scores | * DoF score | 6 X 6 X 4=144 | 1 X 1 X 1=1 |
# samples | 6 | 1 | |
** MAII score | log2(6/144*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: MED4 [Title/Abstract] AND HTR2A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | MED4(48653980)-HTR2A(47409774), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | MED4-HTR2A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MED4-HTR2A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MED4-HTR2A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. MED4-HTR2A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MED4 | GO:0006366 | transcription by RNA polymerase II | 10882111 |
Hgene | MED4 | GO:0006367 | transcription initiation from RNA polymerase II promoter | 12218053 |
Hgene | MED4 | GO:0045893 | positive regulation of transcription, DNA-templated | 10198638 |
Tgene | HTR2A | GO:0006874 | cellular calcium ion homeostasis | 16517693|19057895 |
Tgene | HTR2A | GO:0007202 | activation of phospholipase C activity | 16517693 |
Tgene | HTR2A | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process | 19057895 |
Tgene | HTR2A | GO:0014065 | phosphatidylinositol 3-kinase signaling | 16517693 |
Tgene | HTR2A | GO:0042493 | response to drug | 15862800|18703043 |
Tgene | HTR2A | GO:0051209 | release of sequestered calcium ion into cytosol | 15862800 |
Tgene | HTR2A | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 19057895 |
Fusion gene breakpoints across MED4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across HTR2A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | GBM | TCGA-12-0619-01A | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
Top |
Fusion Gene ORF analysis for MED4-HTR2A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000495013 | ENST00000378688 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
5UTR-3CDS | ENST00000495013 | ENST00000542664 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
5UTR-3CDS | ENST00000495013 | ENST00000543956 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
In-frame | ENST00000258648 | ENST00000378688 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
In-frame | ENST00000258648 | ENST00000542664 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
In-frame | ENST00000258648 | ENST00000543956 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
In-frame | ENST00000378586 | ENST00000378688 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
In-frame | ENST00000378586 | ENST00000542664 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
In-frame | ENST00000378586 | ENST00000543956 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000258648 | MED4 | chr13 | 48653980 | - | ENST00000378688 | HTR2A | chr13 | 47409774 | - | 4756 | 666 | 17 | 1468 | 483 |
ENST00000258648 | MED4 | chr13 | 48653980 | - | ENST00000542664 | HTR2A | chr13 | 47409774 | - | 2928 | 666 | 17 | 1468 | 483 |
ENST00000258648 | MED4 | chr13 | 48653980 | - | ENST00000543956 | HTR2A | chr13 | 47409774 | - | 2928 | 666 | 17 | 1468 | 483 |
ENST00000378586 | MED4 | chr13 | 48653980 | - | ENST00000378688 | HTR2A | chr13 | 47409774 | - | 4677 | 587 | 4 | 1389 | 461 |
ENST00000378586 | MED4 | chr13 | 48653980 | - | ENST00000542664 | HTR2A | chr13 | 47409774 | - | 2849 | 587 | 4 | 1389 | 461 |
ENST00000378586 | MED4 | chr13 | 48653980 | - | ENST00000543956 | HTR2A | chr13 | 47409774 | - | 2849 | 587 | 4 | 1389 | 461 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000258648 | ENST00000378688 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - | 0.00058238 | 0.99941766 |
ENST00000258648 | ENST00000542664 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - | 0.001148096 | 0.9988519 |
ENST00000258648 | ENST00000543956 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - | 0.001148096 | 0.9988519 |
ENST00000378586 | ENST00000378688 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - | 0.000343832 | 0.9996562 |
ENST00000378586 | ENST00000542664 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - | 0.000793712 | 0.99920636 |
ENST00000378586 | ENST00000543956 | MED4 | chr13 | 48653980 | - | HTR2A | chr13 | 47409774 | - | 0.000793712 | 0.99920636 |
Top |
Fusion Genomic Features for MED4-HTR2A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for MED4-HTR2A |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:48653980/chr13:47409774) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MED4 | chr13:48653980 | chr13:47409774 | ENST00000258648 | - | 6 | 7 | 24_48 | 213 | 271.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | MED4 | chr13:48653980 | chr13:47409774 | ENST00000258648 | - | 6 | 7 | 90_131 | 213 | 271.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | MED4 | chr13:48653980 | chr13:47409774 | ENST00000378586 | - | 6 | 7 | 24_48 | 167 | 225.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | MED4 | chr13:48653980 | chr13:47409774 | ENST00000378586 | - | 6 | 7 | 90_131 | 167 | 225.0 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 376_380 | 204 | 472.0 | Motif | NPxxY motif%3B important for ligand-induced conformation changes and signaling | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 469_471 | 204 | 472.0 | Motif | PDZ-binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 376_380 | 204 | 472.0 | Motif | NPxxY motif%3B important for ligand-induced conformation changes and signaling | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 469_471 | 204 | 472.0 | Motif | PDZ-binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 172_174 | 120 | 388.0 | Motif | DRY motif%3B important for ligand-induced conformation changes | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 376_380 | 120 | 388.0 | Motif | NPxxY motif%3B important for ligand-induced conformation changes and signaling | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 469_471 | 120 | 388.0 | Motif | PDZ-binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 336_340 | 204 | 472.0 | Region | Agonist binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 336_340 | 204 | 472.0 | Region | Agonist binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 155_160 | 120 | 388.0 | Region | Agonist binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 336_340 | 120 | 388.0 | Region | Agonist binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 216_233 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 255_324 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 347_362 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 385_471 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 216_233 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 255_324 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 347_362 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 385_471 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 133_148 | 120 | 388.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 172_191 | 120 | 388.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 216_233 | 120 | 388.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 255_324 | 120 | 388.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 347_362 | 120 | 388.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 385_471 | 120 | 388.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 234_254 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 325_346 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 363_384 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 234_254 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 325_346 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 363_384 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 149_171 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 192_215 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 234_254 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 325_346 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 363_384 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D7 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MED4 | chr13:48653980 | chr13:47409774 | ENST00000258648 | - | 6 | 7 | 262_269 | 213 | 271.0 | Compositional bias | Note=Poly-Ser |
Hgene | MED4 | chr13:48653980 | chr13:47409774 | ENST00000378586 | - | 6 | 7 | 262_269 | 167 | 225.0 | Compositional bias | Note=Poly-Ser |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 172_174 | 204 | 472.0 | Motif | DRY motif%3B important for ligand-induced conformation changes | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 172_174 | 204 | 472.0 | Motif | DRY motif%3B important for ligand-induced conformation changes | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 155_160 | 204 | 472.0 | Region | Agonist binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 155_160 | 204 | 472.0 | Region | Agonist binding | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 100_110 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 133_148 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 172_191 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 1_75 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 100_110 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 133_148 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 172_191 | 204 | 472.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 1_75 | 204 | 472.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 100_110 | 120 | 388.0 | Topological domain | Cytoplasmic | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 1_75 | 120 | 388.0 | Topological domain | Extracellular | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 111_132 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 149_171 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 192_215 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000378688 | 1 | 3 | 76_99 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 111_132 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 149_171 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 192_215 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000542664 | 2 | 4 | 76_99 | 204 | 472.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 111_132 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | HTR2A | chr13:48653980 | chr13:47409774 | ENST00000543956 | 1 | 3 | 76_99 | 120 | 388.0 | Transmembrane | Helical%3B Name%3D1 |
Top |
Fusion Gene Sequence for MED4-HTR2A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>52779_52779_1_MED4-HTR2A_MED4_chr13_48653980_ENST00000258648_HTR2A_chr13_47409774_ENST00000378688_length(transcript)=4756nt_BP=666nt GCGCCGGTGGCGGGACTCTGGGGAAAATGGCTGCGTCTTCGAGTGGTGAGAAGGAGAAGGAGCGGCTGGGAGGCGGTTTGGGAGTGGCGG GTGGTAACAGCACACGAGAGCGGCTGCTGTCTGCGCTTGAGGACTTGGAGGTCCTGTCTAGGGAACTTATAGAAATGCTGGCAATTTCAA GAAACCAAAAGTTGTTACAGGCTGGAGAGGAAAACCAGGTCCTGGAGTTGTTAATTCACCGAGATGGGGAATTTCAAGAACTAATGAAAT TGGCACTTAATCAGGGAAAAATTCATCATGAAATGCAAGTTTTAGAAAAAGAAGTAGAGAAGAGAGACAGTGATATTCAGCAGCTACAAA AACAGCTAAAGGAAGCAGAACAAATACTGGCAACAGCTGTTTACCAAGCGAAGGAGAAACTCAAGTCAATAGAAAAAGCAAGAAAAGGTG CTATCTCCTCTGAAGAAATAATTAAGTATGCACATAGGATCAGTGCAAGTAATGCTGTATGTGCTCCACTGACCTGGGTTCCAGGGGACC CCCGGAGACCCTACCCAACTGATTTAGAGATGAGAAGTGGGTTACTGGGTCAGATGAACAATCCTTCCACTAATGGCGTGAATGGCCATT TACCAGGAGATGCACTTGCAGCAGGAAGATTGCCAGGTATATCCATGCCAATACCAGTCTTTGGGCTACAGGACGATTCGAAGGTCTTTA AGGAGGGGAGTTGCTTACTCGCCGATGATAACTTTGTCCTGATCGGCTCTTTTGTGTCATTTTTCATTCCCTTAACCATCATGGTGATCA CCTACTTTCTAACTATCAAGTCACTCCAGAAAGAAGCTACTTTGTGTGTAAGTGATCTTGGCACACGGGCCAAATTAGCTTCTTTCAGCT TCCTCCCTCAGAGTTCTTTGTCTTCAGAAAAGCTCTTCCAGCGGTCGATCCATAGGGAGCCAGGGTCCTACACAGGCAGGAGGACTATGC AGTCCATCAGCAATGAGCAAAAGGCATGCAAGGTGCTGGGCATCGTCTTCTTCCTGTTTGTGGTGATGTGGTGCCCTTTCTTCATCACAA ACATCATGGCCGTCATCTGCAAAGAGTCCTGCAATGAGGATGTCATTGGGGCCCTGCTCAATGTGTTTGTTTGGATCGGTTATCTCTCTT CAGCAGTCAACCCACTAGTCTACACACTGTTCAACAAGACCTATAGGTCAGCCTTTTCACGGTATATTCAGTGTCAGTACAAGGAAAACA AAAAACCATTGCAGTTAATTTTAGTGAACACAATACCGGCTTTGGCCTACAAGTCTAGCCAACTTCAAATGGGACAAAAAAAGAATTCAA AGCAAGATGCCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAGCAGCATTCTGAAGAGGCTTCTAAAGACAATAGCGACG GAGTGAATGAAAAGGTGAGCTGTGTGTGATAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCACCTATCTGGAAA AAAAAAAATATGAGATTGGAAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTGTCAATGAAAAG CGGGGTTCAATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTATAACATTGTAA ATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCAAGTGGAAACCT TGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTATAAATAGTGAAAATTTTATTG AATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGGAGAAAAAAAAAGCCACTAAGGTCAGTGTTAT AAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTTCATTCCTGCTTTTTCATAGATACCATTTTGAAATATTCACA AGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAGAAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCTGCTTTCTCTTC TACTTCTTGTGCTTTACTCTGAATTTCCAGTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATGATTTAACATTA CCAAATGCCTTTCTAGCAATTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATCATGCATGCACT CTTTTGAGCAGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGTAGAGTCCTAGG ACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACTATTTATTAAAA CCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGAGAAATATAAAAATAATTAAAA CAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAATCCTAGCACTTTGGGAGGCTGAGATGGGAGGA TCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACCTCCCTGTCTCTACAAAAAAAATCAAAAAATTATCTGATCCT TGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTGAGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCAGTGAGCCAAGT TCACACCACTGCCATTTCCTCCTGGGCAACAGAGTGAGACCCTATCACAAAAAAAAAGAAAGAAAAAAAGAAAATGACTAAACTGAAATG GTCTTAGTCAAAAAATATATACAGACTTATTTTTAGAATCATTTCAACTTATTTCCTTCTTACCTGGTTCAGAAACAAGTTTGTTTCAAC TGTGAGAGTAGTTTTAAAAATAAGTTTTCCTGATTGGTTACCAATAAACACCAAACAAATAAAGGAGGGGGAAAATATCACTTGAGGCTT AACATTGCAATTAATTTAGAAATACGCACCTCAATCTCAAGCCAGTTTATAACTACCATAGTTTTGAGCAAAATTTTTCTTCTATTTCTC CAAAAACTCACTCATTTCAGTATTACTCATTGACACTGGGCTCCCTAATAGAAAAGCAGATATTATAATATTTCATTGAAATGGTTACTA AAGAGAAAAAGAGATTAACAACAGTTAATCCACCTTGATATTATAACACTCAAGGTTAAATTGCATGTTGTTATTAGAATCAATGTTATA TATATGATTACAATGCTGAAGCATTTCTATTGAATGAGAAATAGTGTTTGCCCTAAACCTTTGGGAAAAAAATACAGATTTGAAAACTAA AGAATGTGGGAAGTGTCATTGTGTAATTTGGAAATGCATAAAATTCTCATTATGTCCTCATAGATATGTTGAAAGATGGTTCACTGTTTC AAAGATAGAATGTATAATATGCTGCTAGTACCAAGGCTGCATTTGAACTGAACTACTCCTTATGATATACCATACTAACTGATGAAAATA TAAATGTTAAAATGTCTCCACTCTAATGTATTTTGCCTTCACTTGTAACTCTGCACATTTCATTATATATTAGGGAAAAGATTACAGATT CTACCCCCATATACTCAATCTTGATCAGAATGTACATTAATGTTGCCTGATAGATGTCTTTTGACTACCTATATATTACAAATGTGTATG TGTTTTTTTCTTCCATAAGTATCTATTCAAGTGTATACTGTATAGGCAAATGTGTAGCTGTATATATGTACAGACATGTTCTCATGCACT TTATTCAATATTTATATATTTATATGGACGAAAAGCAAGTCAATGAAAACACTCAGTATATACACATGTGTGCATGTTTGTATCATGTTT ATTTAAATGTGAATTCATGTTCTAATATTTCTATGACCTTCCATTGCTGCAAAGCAGATTAAAGTGTAACAAAAATATCAGCTCTTTAAA TAAACTGGAAATTAATCTAATTTTGTGGAAGAACTTTAAGACAAGTCTATGAGGATGGCGAAAACAATGGTCCACATATATAGTTTCTTG ATCCTAAATAAAATGGTACCTTTGGGCCCTTTGTTTAGTCTGGCAATTTTCTGACTACTATGGCTTTTTAAACAGACTCACACCTAAGTG AAACACAGTTGTCAAATGATTTATGGATCTGTGATTAAAGGATTCACTTTTAATGAATACTATTAAAACGGAGTAACAAACCTTGCTCTA CTTTAAGTTGAATGATAGATTCCTCTATATTCAAAAAAAAGCAATTAACTGCCATAATTAGGGAAAACTGTTTAAAGCATACTGCATTTA CTTGGCCACAGCGCCATCTCATGGTAATTTTTTAAAGTGCTACCGTAGCCAAATTGAACTAAGTCACTGTACTGCTTTCAGCAAAGGGTG CTCCTCCCATTTGTGCATCAATGAGACATATTTATAAAGTGCTAAATTATTCTGTGCCATATGTAACAAATACAGTGAAGATTATTTTAT >52779_52779_1_MED4-HTR2A_MED4_chr13_48653980_ENST00000258648_HTR2A_chr13_47409774_ENST00000378688_length(amino acids)=483AA_BP=1 MGKMAASSSGEKEKERLGGGLGVAGGNSTRERLLSALEDLEVLSRELIEMLAISRNQKLLQAGEENQVLELLIHRDGEFQELMKLALNQG KIHHEMQVLEKEVEKRDSDIQQLQKQLKEAEQILATAVYQAKEKLKSIEKARKGAISSEEIIKYAHRISASNAVCAPLTWVPGDPRRPYP TDLEMRSGLLGQMNNPSTNGVNGHLPGDALAAGRLPGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTI KSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVI CKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKT -------------------------------------------------------------- >52779_52779_2_MED4-HTR2A_MED4_chr13_48653980_ENST00000258648_HTR2A_chr13_47409774_ENST00000542664_length(transcript)=2928nt_BP=666nt GCGCCGGTGGCGGGACTCTGGGGAAAATGGCTGCGTCTTCGAGTGGTGAGAAGGAGAAGGAGCGGCTGGGAGGCGGTTTGGGAGTGGCGG GTGGTAACAGCACACGAGAGCGGCTGCTGTCTGCGCTTGAGGACTTGGAGGTCCTGTCTAGGGAACTTATAGAAATGCTGGCAATTTCAA GAAACCAAAAGTTGTTACAGGCTGGAGAGGAAAACCAGGTCCTGGAGTTGTTAATTCACCGAGATGGGGAATTTCAAGAACTAATGAAAT TGGCACTTAATCAGGGAAAAATTCATCATGAAATGCAAGTTTTAGAAAAAGAAGTAGAGAAGAGAGACAGTGATATTCAGCAGCTACAAA AACAGCTAAAGGAAGCAGAACAAATACTGGCAACAGCTGTTTACCAAGCGAAGGAGAAACTCAAGTCAATAGAAAAAGCAAGAAAAGGTG CTATCTCCTCTGAAGAAATAATTAAGTATGCACATAGGATCAGTGCAAGTAATGCTGTATGTGCTCCACTGACCTGGGTTCCAGGGGACC CCCGGAGACCCTACCCAACTGATTTAGAGATGAGAAGTGGGTTACTGGGTCAGATGAACAATCCTTCCACTAATGGCGTGAATGGCCATT TACCAGGAGATGCACTTGCAGCAGGAAGATTGCCAGGTATATCCATGCCAATACCAGTCTTTGGGCTACAGGACGATTCGAAGGTCTTTA AGGAGGGGAGTTGCTTACTCGCCGATGATAACTTTGTCCTGATCGGCTCTTTTGTGTCATTTTTCATTCCCTTAACCATCATGGTGATCA CCTACTTTCTAACTATCAAGTCACTCCAGAAAGAAGCTACTTTGTGTGTAAGTGATCTTGGCACACGGGCCAAATTAGCTTCTTTCAGCT TCCTCCCTCAGAGTTCTTTGTCTTCAGAAAAGCTCTTCCAGCGGTCGATCCATAGGGAGCCAGGGTCCTACACAGGCAGGAGGACTATGC AGTCCATCAGCAATGAGCAAAAGGCATGCAAGGTGCTGGGCATCGTCTTCTTCCTGTTTGTGGTGATGTGGTGCCCTTTCTTCATCACAA ACATCATGGCCGTCATCTGCAAAGAGTCCTGCAATGAGGATGTCATTGGGGCCCTGCTCAATGTGTTTGTTTGGATCGGTTATCTCTCTT CAGCAGTCAACCCACTAGTCTACACACTGTTCAACAAGACCTATAGGTCAGCCTTTTCACGGTATATTCAGTGTCAGTACAAGGAAAACA AAAAACCATTGCAGTTAATTTTAGTGAACACAATACCGGCTTTGGCCTACAAGTCTAGCCAACTTCAAATGGGACAAAAAAAGAATTCAA AGCAAGATGCCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAGCAGCATTCTGAAGAGGCTTCTAAAGACAATAGCGACG GAGTGAATGAAAAGGTGAGCTGTGTGTGATAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCACCTATCTGGAAA AAAAAAAATATGAGATTGGAAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTGTCAATGAAAAG CGGGGTTCAATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTATAACATTGTAA ATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCAAGTGGAAACCT TGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTATAAATAGTGAAAATTTTATTG AATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGGAGAAAAAAAAAGCCACTAAGGTCAGTGTTAT AAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTTCATTCCTGCTTTTTCATAGATACCATTTTGAAATATTCACA AGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAGAAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCTGCTTTCTCTTC TACTTCTTGTGCTTTACTCTGAATTTCCAGTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATGATTTAACATTA CCAAATGCCTTTCTAGCAATTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATCATGCATGCACT CTTTTGAGCAGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGTAGAGTCCTAGG ACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACTATTTATTAAAA CCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGAGAAATATAAAAATAATTAAAA CAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAATCCTAGCACTTTGGGAGGCTGAGATGGGAGGA TCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACCTCCCTGTCTCTACAAAAAAAATCAAAAAATTATCTGATCCT TGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTGAGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCAGTGAGCCAAGT >52779_52779_2_MED4-HTR2A_MED4_chr13_48653980_ENST00000258648_HTR2A_chr13_47409774_ENST00000542664_length(amino acids)=483AA_BP=1 MGKMAASSSGEKEKERLGGGLGVAGGNSTRERLLSALEDLEVLSRELIEMLAISRNQKLLQAGEENQVLELLIHRDGEFQELMKLALNQG KIHHEMQVLEKEVEKRDSDIQQLQKQLKEAEQILATAVYQAKEKLKSIEKARKGAISSEEIIKYAHRISASNAVCAPLTWVPGDPRRPYP TDLEMRSGLLGQMNNPSTNGVNGHLPGDALAAGRLPGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTI KSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVI CKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKT -------------------------------------------------------------- >52779_52779_3_MED4-HTR2A_MED4_chr13_48653980_ENST00000258648_HTR2A_chr13_47409774_ENST00000543956_length(transcript)=2928nt_BP=666nt GCGCCGGTGGCGGGACTCTGGGGAAAATGGCTGCGTCTTCGAGTGGTGAGAAGGAGAAGGAGCGGCTGGGAGGCGGTTTGGGAGTGGCGG GTGGTAACAGCACACGAGAGCGGCTGCTGTCTGCGCTTGAGGACTTGGAGGTCCTGTCTAGGGAACTTATAGAAATGCTGGCAATTTCAA GAAACCAAAAGTTGTTACAGGCTGGAGAGGAAAACCAGGTCCTGGAGTTGTTAATTCACCGAGATGGGGAATTTCAAGAACTAATGAAAT TGGCACTTAATCAGGGAAAAATTCATCATGAAATGCAAGTTTTAGAAAAAGAAGTAGAGAAGAGAGACAGTGATATTCAGCAGCTACAAA AACAGCTAAAGGAAGCAGAACAAATACTGGCAACAGCTGTTTACCAAGCGAAGGAGAAACTCAAGTCAATAGAAAAAGCAAGAAAAGGTG CTATCTCCTCTGAAGAAATAATTAAGTATGCACATAGGATCAGTGCAAGTAATGCTGTATGTGCTCCACTGACCTGGGTTCCAGGGGACC CCCGGAGACCCTACCCAACTGATTTAGAGATGAGAAGTGGGTTACTGGGTCAGATGAACAATCCTTCCACTAATGGCGTGAATGGCCATT TACCAGGAGATGCACTTGCAGCAGGAAGATTGCCAGGTATATCCATGCCAATACCAGTCTTTGGGCTACAGGACGATTCGAAGGTCTTTA AGGAGGGGAGTTGCTTACTCGCCGATGATAACTTTGTCCTGATCGGCTCTTTTGTGTCATTTTTCATTCCCTTAACCATCATGGTGATCA CCTACTTTCTAACTATCAAGTCACTCCAGAAAGAAGCTACTTTGTGTGTAAGTGATCTTGGCACACGGGCCAAATTAGCTTCTTTCAGCT TCCTCCCTCAGAGTTCTTTGTCTTCAGAAAAGCTCTTCCAGCGGTCGATCCATAGGGAGCCAGGGTCCTACACAGGCAGGAGGACTATGC AGTCCATCAGCAATGAGCAAAAGGCATGCAAGGTGCTGGGCATCGTCTTCTTCCTGTTTGTGGTGATGTGGTGCCCTTTCTTCATCACAA ACATCATGGCCGTCATCTGCAAAGAGTCCTGCAATGAGGATGTCATTGGGGCCCTGCTCAATGTGTTTGTTTGGATCGGTTATCTCTCTT CAGCAGTCAACCCACTAGTCTACACACTGTTCAACAAGACCTATAGGTCAGCCTTTTCACGGTATATTCAGTGTCAGTACAAGGAAAACA AAAAACCATTGCAGTTAATTTTAGTGAACACAATACCGGCTTTGGCCTACAAGTCTAGCCAACTTCAAATGGGACAAAAAAAGAATTCAA AGCAAGATGCCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAGCAGCATTCTGAAGAGGCTTCTAAAGACAATAGCGACG GAGTGAATGAAAAGGTGAGCTGTGTGTGATAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCACCTATCTGGAAA AAAAAAAATATGAGATTGGAAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTGTCAATGAAAAG CGGGGTTCAATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTATAACATTGTAA ATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCAAGTGGAAACCT TGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTATAAATAGTGAAAATTTTATTG AATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGGAGAAAAAAAAAGCCACTAAGGTCAGTGTTAT AAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTTCATTCCTGCTTTTTCATAGATACCATTTTGAAATATTCACA AGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAGAAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCTGCTTTCTCTTC TACTTCTTGTGCTTTACTCTGAATTTCCAGTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATGATTTAACATTA CCAAATGCCTTTCTAGCAATTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATCATGCATGCACT CTTTTGAGCAGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGTAGAGTCCTAGG ACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACTATTTATTAAAA CCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGAGAAATATAAAAATAATTAAAA CAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAATCCTAGCACTTTGGGAGGCTGAGATGGGAGGA TCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACCTCCCTGTCTCTACAAAAAAAATCAAAAAATTATCTGATCCT TGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTGAGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCAGTGAGCCAAGT >52779_52779_3_MED4-HTR2A_MED4_chr13_48653980_ENST00000258648_HTR2A_chr13_47409774_ENST00000543956_length(amino acids)=483AA_BP=1 MGKMAASSSGEKEKERLGGGLGVAGGNSTRERLLSALEDLEVLSRELIEMLAISRNQKLLQAGEENQVLELLIHRDGEFQELMKLALNQG KIHHEMQVLEKEVEKRDSDIQQLQKQLKEAEQILATAVYQAKEKLKSIEKARKGAISSEEIIKYAHRISASNAVCAPLTWVPGDPRRPYP TDLEMRSGLLGQMNNPSTNGVNGHLPGDALAAGRLPGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTI KSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVI CKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKT -------------------------------------------------------------- >52779_52779_4_MED4-HTR2A_MED4_chr13_48653980_ENST00000378586_HTR2A_chr13_47409774_ENST00000378688_length(transcript)=4677nt_BP=587nt GCACCTGCGTCAGCTCGCTCTGCGCGTGCGCCGGTGGCGGGACTCTGGGGAAAATGGCTGCGTCTTCGAGTGGGAACTTATAGAAATGCT GGCAATTTCAAGAAACCAAAAGTTGTTACAGGCTGGAGAGGAAAACCAGGTCCTGGAGTTGTTAATTCACCGAGATGGGGAATTTCAAGA ACTAATGAAATTGGCACTTAATCAGGGAAAAATTCATCATGAAATGCAAGTTTTAGAAAAAGAAGTAGAGAAGAGAGACAGTGATATTCA GCAGCTACAAAAACAGCTAAAGGAAGCAGAACAAATACTGGCAACAGCTGTTTACCAAGCGAAGGAGAAACTCAAGTCAATAGAAAAAGC AAGAAAAGGTGCTATCTCCTCTGAAGAAATAATTAAGTATGCACATAGGATCAGTGCAAGTAATGCTGTATGTGCTCCACTGACCTGGGT TCCAGGGGACCCCCGGAGACCCTACCCAACTGATTTAGAGATGAGAAGTGGGTTACTGGGTCAGATGAACAATCCTTCCACTAATGGCGT GAATGGCCATTTACCAGGAGATGCACTTGCAGCAGGAAGATTGCCAGGTATATCCATGCCAATACCAGTCTTTGGGCTACAGGACGATTC GAAGGTCTTTAAGGAGGGGAGTTGCTTACTCGCCGATGATAACTTTGTCCTGATCGGCTCTTTTGTGTCATTTTTCATTCCCTTAACCAT CATGGTGATCACCTACTTTCTAACTATCAAGTCACTCCAGAAAGAAGCTACTTTGTGTGTAAGTGATCTTGGCACACGGGCCAAATTAGC TTCTTTCAGCTTCCTCCCTCAGAGTTCTTTGTCTTCAGAAAAGCTCTTCCAGCGGTCGATCCATAGGGAGCCAGGGTCCTACACAGGCAG GAGGACTATGCAGTCCATCAGCAATGAGCAAAAGGCATGCAAGGTGCTGGGCATCGTCTTCTTCCTGTTTGTGGTGATGTGGTGCCCTTT CTTCATCACAAACATCATGGCCGTCATCTGCAAAGAGTCCTGCAATGAGGATGTCATTGGGGCCCTGCTCAATGTGTTTGTTTGGATCGG TTATCTCTCTTCAGCAGTCAACCCACTAGTCTACACACTGTTCAACAAGACCTATAGGTCAGCCTTTTCACGGTATATTCAGTGTCAGTA CAAGGAAAACAAAAAACCATTGCAGTTAATTTTAGTGAACACAATACCGGCTTTGGCCTACAAGTCTAGCCAACTTCAAATGGGACAAAA AAAGAATTCAAAGCAAGATGCCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAGCAGCATTCTGAAGAGGCTTCTAAAGA CAATAGCGACGGAGTGAATGAAAAGGTGAGCTGTGTGTGATAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCAC CTATCTGGAAAAAAAAAAATATGAGATTGGAAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTG TCAATGAAAAGCGGGGTTCAATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTA TAACATTGTAAATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCA AGTGGAAACCTTGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTATAAATAGTGA AAATTTTATTGAATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGGAGAAAAAAAAAGCCACTAAG GTCAGTGTTATAAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTTCATTCCTGCTTTTTCATAGATACCATTTTG AAATATTCACAAGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAGAAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCT GCTTTCTCTTCTACTTCTTGTGCTTTACTCTGAATTTCCAGTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATG ATTTAACATTACCAAATGCCTTTCTAGCAATTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATC ATGCATGCACTCTTTTGAGCAGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGT AGAGTCCTAGGACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACT ATTTATTAAAACCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGAGAAATATAAA AATAATTAAAACAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAATCCTAGCACTTTGGGAGGCTG AGATGGGAGGATCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACCTCCCTGTCTCTACAAAAAAAATCAAAAAAT TATCTGATCCTTGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTGAGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCA GTGAGCCAAGTTCACACCACTGCCATTTCCTCCTGGGCAACAGAGTGAGACCCTATCACAAAAAAAAAGAAAGAAAAAAAGAAAATGACT AAACTGAAATGGTCTTAGTCAAAAAATATATACAGACTTATTTTTAGAATCATTTCAACTTATTTCCTTCTTACCTGGTTCAGAAACAAG TTTGTTTCAACTGTGAGAGTAGTTTTAAAAATAAGTTTTCCTGATTGGTTACCAATAAACACCAAACAAATAAAGGAGGGGGAAAATATC ACTTGAGGCTTAACATTGCAATTAATTTAGAAATACGCACCTCAATCTCAAGCCAGTTTATAACTACCATAGTTTTGAGCAAAATTTTTC TTCTATTTCTCCAAAAACTCACTCATTTCAGTATTACTCATTGACACTGGGCTCCCTAATAGAAAAGCAGATATTATAATATTTCATTGA AATGGTTACTAAAGAGAAAAAGAGATTAACAACAGTTAATCCACCTTGATATTATAACACTCAAGGTTAAATTGCATGTTGTTATTAGAA TCAATGTTATATATATGATTACAATGCTGAAGCATTTCTATTGAATGAGAAATAGTGTTTGCCCTAAACCTTTGGGAAAAAAATACAGAT TTGAAAACTAAAGAATGTGGGAAGTGTCATTGTGTAATTTGGAAATGCATAAAATTCTCATTATGTCCTCATAGATATGTTGAAAGATGG TTCACTGTTTCAAAGATAGAATGTATAATATGCTGCTAGTACCAAGGCTGCATTTGAACTGAACTACTCCTTATGATATACCATACTAAC TGATGAAAATATAAATGTTAAAATGTCTCCACTCTAATGTATTTTGCCTTCACTTGTAACTCTGCACATTTCATTATATATTAGGGAAAA GATTACAGATTCTACCCCCATATACTCAATCTTGATCAGAATGTACATTAATGTTGCCTGATAGATGTCTTTTGACTACCTATATATTAC AAATGTGTATGTGTTTTTTTCTTCCATAAGTATCTATTCAAGTGTATACTGTATAGGCAAATGTGTAGCTGTATATATGTACAGACATGT TCTCATGCACTTTATTCAATATTTATATATTTATATGGACGAAAAGCAAGTCAATGAAAACACTCAGTATATACACATGTGTGCATGTTT GTATCATGTTTATTTAAATGTGAATTCATGTTCTAATATTTCTATGACCTTCCATTGCTGCAAAGCAGATTAAAGTGTAACAAAAATATC AGCTCTTTAAATAAACTGGAAATTAATCTAATTTTGTGGAAGAACTTTAAGACAAGTCTATGAGGATGGCGAAAACAATGGTCCACATAT ATAGTTTCTTGATCCTAAATAAAATGGTACCTTTGGGCCCTTTGTTTAGTCTGGCAATTTTCTGACTACTATGGCTTTTTAAACAGACTC ACACCTAAGTGAAACACAGTTGTCAAATGATTTATGGATCTGTGATTAAAGGATTCACTTTTAATGAATACTATTAAAACGGAGTAACAA ACCTTGCTCTACTTTAAGTTGAATGATAGATTCCTCTATATTCAAAAAAAAGCAATTAACTGCCATAATTAGGGAAAACTGTTTAAAGCA TACTGCATTTACTTGGCCACAGCGCCATCTCATGGTAATTTTTTAAAGTGCTACCGTAGCCAAATTGAACTAAGTCACTGTACTGCTTTC AGCAAAGGGTGCTCCTCCCATTTGTGCATCAATGAGACATATTTATAAAGTGCTAAATTATTCTGTGCCATATGTAACAAATACAGTGAA >52779_52779_4_MED4-HTR2A_MED4_chr13_48653980_ENST00000378586_HTR2A_chr13_47409774_ENST00000378688_length(amino acids)=461AA_BP=1 MRQLALRVRRWRDSGENGCVFEWELIEMLAISRNQKLLQAGEENQVLELLIHRDGEFQELMKLALNQGKIHHEMQVLEKEVEKRDSDIQQ LQKQLKEAEQILATAVYQAKEKLKSIEKARKGAISSEEIIKYAHRISASNAVCAPLTWVPGDPRRPYPTDLEMRSGLLGQMNNPSTNGVN GHLPGDALAAGRLPGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLAS FSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGY LSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDN -------------------------------------------------------------- >52779_52779_5_MED4-HTR2A_MED4_chr13_48653980_ENST00000378586_HTR2A_chr13_47409774_ENST00000542664_length(transcript)=2849nt_BP=587nt GCACCTGCGTCAGCTCGCTCTGCGCGTGCGCCGGTGGCGGGACTCTGGGGAAAATGGCTGCGTCTTCGAGTGGGAACTTATAGAAATGCT GGCAATTTCAAGAAACCAAAAGTTGTTACAGGCTGGAGAGGAAAACCAGGTCCTGGAGTTGTTAATTCACCGAGATGGGGAATTTCAAGA ACTAATGAAATTGGCACTTAATCAGGGAAAAATTCATCATGAAATGCAAGTTTTAGAAAAAGAAGTAGAGAAGAGAGACAGTGATATTCA GCAGCTACAAAAACAGCTAAAGGAAGCAGAACAAATACTGGCAACAGCTGTTTACCAAGCGAAGGAGAAACTCAAGTCAATAGAAAAAGC AAGAAAAGGTGCTATCTCCTCTGAAGAAATAATTAAGTATGCACATAGGATCAGTGCAAGTAATGCTGTATGTGCTCCACTGACCTGGGT TCCAGGGGACCCCCGGAGACCCTACCCAACTGATTTAGAGATGAGAAGTGGGTTACTGGGTCAGATGAACAATCCTTCCACTAATGGCGT GAATGGCCATTTACCAGGAGATGCACTTGCAGCAGGAAGATTGCCAGGTATATCCATGCCAATACCAGTCTTTGGGCTACAGGACGATTC GAAGGTCTTTAAGGAGGGGAGTTGCTTACTCGCCGATGATAACTTTGTCCTGATCGGCTCTTTTGTGTCATTTTTCATTCCCTTAACCAT CATGGTGATCACCTACTTTCTAACTATCAAGTCACTCCAGAAAGAAGCTACTTTGTGTGTAAGTGATCTTGGCACACGGGCCAAATTAGC TTCTTTCAGCTTCCTCCCTCAGAGTTCTTTGTCTTCAGAAAAGCTCTTCCAGCGGTCGATCCATAGGGAGCCAGGGTCCTACACAGGCAG GAGGACTATGCAGTCCATCAGCAATGAGCAAAAGGCATGCAAGGTGCTGGGCATCGTCTTCTTCCTGTTTGTGGTGATGTGGTGCCCTTT CTTCATCACAAACATCATGGCCGTCATCTGCAAAGAGTCCTGCAATGAGGATGTCATTGGGGCCCTGCTCAATGTGTTTGTTTGGATCGG TTATCTCTCTTCAGCAGTCAACCCACTAGTCTACACACTGTTCAACAAGACCTATAGGTCAGCCTTTTCACGGTATATTCAGTGTCAGTA CAAGGAAAACAAAAAACCATTGCAGTTAATTTTAGTGAACACAATACCGGCTTTGGCCTACAAGTCTAGCCAACTTCAAATGGGACAAAA AAAGAATTCAAAGCAAGATGCCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAGCAGCATTCTGAAGAGGCTTCTAAAGA CAATAGCGACGGAGTGAATGAAAAGGTGAGCTGTGTGTGATAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCAC CTATCTGGAAAAAAAAAAATATGAGATTGGAAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTG TCAATGAAAAGCGGGGTTCAATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTA TAACATTGTAAATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCA AGTGGAAACCTTGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTATAAATAGTGA AAATTTTATTGAATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGGAGAAAAAAAAAGCCACTAAG GTCAGTGTTATAAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTTCATTCCTGCTTTTTCATAGATACCATTTTG AAATATTCACAAGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAGAAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCT GCTTTCTCTTCTACTTCTTGTGCTTTACTCTGAATTTCCAGTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATG ATTTAACATTACCAAATGCCTTTCTAGCAATTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATC ATGCATGCACTCTTTTGAGCAGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGT AGAGTCCTAGGACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACT ATTTATTAAAACCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGAGAAATATAAA AATAATTAAAACAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAATCCTAGCACTTTGGGAGGCTG AGATGGGAGGATCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACCTCCCTGTCTCTACAAAAAAAATCAAAAAAT TATCTGATCCTTGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTGAGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCA >52779_52779_5_MED4-HTR2A_MED4_chr13_48653980_ENST00000378586_HTR2A_chr13_47409774_ENST00000542664_length(amino acids)=461AA_BP=1 MRQLALRVRRWRDSGENGCVFEWELIEMLAISRNQKLLQAGEENQVLELLIHRDGEFQELMKLALNQGKIHHEMQVLEKEVEKRDSDIQQ LQKQLKEAEQILATAVYQAKEKLKSIEKARKGAISSEEIIKYAHRISASNAVCAPLTWVPGDPRRPYPTDLEMRSGLLGQMNNPSTNGVN GHLPGDALAAGRLPGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLAS FSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGY LSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDN -------------------------------------------------------------- >52779_52779_6_MED4-HTR2A_MED4_chr13_48653980_ENST00000378586_HTR2A_chr13_47409774_ENST00000543956_length(transcript)=2849nt_BP=587nt GCACCTGCGTCAGCTCGCTCTGCGCGTGCGCCGGTGGCGGGACTCTGGGGAAAATGGCTGCGTCTTCGAGTGGGAACTTATAGAAATGCT GGCAATTTCAAGAAACCAAAAGTTGTTACAGGCTGGAGAGGAAAACCAGGTCCTGGAGTTGTTAATTCACCGAGATGGGGAATTTCAAGA ACTAATGAAATTGGCACTTAATCAGGGAAAAATTCATCATGAAATGCAAGTTTTAGAAAAAGAAGTAGAGAAGAGAGACAGTGATATTCA GCAGCTACAAAAACAGCTAAAGGAAGCAGAACAAATACTGGCAACAGCTGTTTACCAAGCGAAGGAGAAACTCAAGTCAATAGAAAAAGC AAGAAAAGGTGCTATCTCCTCTGAAGAAATAATTAAGTATGCACATAGGATCAGTGCAAGTAATGCTGTATGTGCTCCACTGACCTGGGT TCCAGGGGACCCCCGGAGACCCTACCCAACTGATTTAGAGATGAGAAGTGGGTTACTGGGTCAGATGAACAATCCTTCCACTAATGGCGT GAATGGCCATTTACCAGGAGATGCACTTGCAGCAGGAAGATTGCCAGGTATATCCATGCCAATACCAGTCTTTGGGCTACAGGACGATTC GAAGGTCTTTAAGGAGGGGAGTTGCTTACTCGCCGATGATAACTTTGTCCTGATCGGCTCTTTTGTGTCATTTTTCATTCCCTTAACCAT CATGGTGATCACCTACTTTCTAACTATCAAGTCACTCCAGAAAGAAGCTACTTTGTGTGTAAGTGATCTTGGCACACGGGCCAAATTAGC TTCTTTCAGCTTCCTCCCTCAGAGTTCTTTGTCTTCAGAAAAGCTCTTCCAGCGGTCGATCCATAGGGAGCCAGGGTCCTACACAGGCAG GAGGACTATGCAGTCCATCAGCAATGAGCAAAAGGCATGCAAGGTGCTGGGCATCGTCTTCTTCCTGTTTGTGGTGATGTGGTGCCCTTT CTTCATCACAAACATCATGGCCGTCATCTGCAAAGAGTCCTGCAATGAGGATGTCATTGGGGCCCTGCTCAATGTGTTTGTTTGGATCGG TTATCTCTCTTCAGCAGTCAACCCACTAGTCTACACACTGTTCAACAAGACCTATAGGTCAGCCTTTTCACGGTATATTCAGTGTCAGTA CAAGGAAAACAAAAAACCATTGCAGTTAATTTTAGTGAACACAATACCGGCTTTGGCCTACAAGTCTAGCCAACTTCAAATGGGACAAAA AAAGAATTCAAAGCAAGATGCCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAGCAGCATTCTGAAGAGGCTTCTAAAGA CAATAGCGACGGAGTGAATGAAAAGGTGAGCTGTGTGTGATAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCAC CTATCTGGAAAAAAAAAAATATGAGATTGGAAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTG TCAATGAAAAGCGGGGTTCAATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTA TAACATTGTAAATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCA AGTGGAAACCTTGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTATAAATAGTGA AAATTTTATTGAATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGGAGAAAAAAAAAGCCACTAAG GTCAGTGTTATAAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTTCATTCCTGCTTTTTCATAGATACCATTTTG AAATATTCACAAGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAGAAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCT GCTTTCTCTTCTACTTCTTGTGCTTTACTCTGAATTTCCAGTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATG ATTTAACATTACCAAATGCCTTTCTAGCAATTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATC ATGCATGCACTCTTTTGAGCAGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGT AGAGTCCTAGGACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACT ATTTATTAAAACCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGAGAAATATAAA AATAATTAAAACAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAATCCTAGCACTTTGGGAGGCTG AGATGGGAGGATCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACCTCCCTGTCTCTACAAAAAAAATCAAAAAAT TATCTGATCCTTGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTGAGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCA >52779_52779_6_MED4-HTR2A_MED4_chr13_48653980_ENST00000378586_HTR2A_chr13_47409774_ENST00000543956_length(amino acids)=461AA_BP=1 MRQLALRVRRWRDSGENGCVFEWELIEMLAISRNQKLLQAGEENQVLELLIHRDGEFQELMKLALNQGKIHHEMQVLEKEVEKRDSDIQQ LQKQLKEAEQILATAVYQAKEKLKSIEKARKGAISSEEIIKYAHRISASNAVCAPLTWVPGDPRRPYPTDLEMRSGLLGQMNNPSTNGVN GHLPGDALAAGRLPGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLAS FSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGY LSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDN -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for MED4-HTR2A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for MED4-HTR2A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for MED4-HTR2A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MED4 | C0014175 | Endometriosis | 1 | CTD_human |
Hgene | MED4 | C0269102 | Endometrioma | 1 | CTD_human |
Tgene | C0005586 | Bipolar Disorder | 6 | CTD_human;PSYGENET | |
Tgene | C0001973 | Alcoholic Intoxication, Chronic | 5 | CTD_human;PSYGENET | |
Tgene | C0011570 | Mental Depression | 5 | PSYGENET | |
Tgene | C0011581 | Depressive disorder | 5 | PSYGENET | |
Tgene | C0041696 | Unipolar Depression | 5 | PSYGENET | |
Tgene | C0085159 | Seasonal Affective Disorder | 5 | PSYGENET | |
Tgene | C0525045 | Mood Disorders | 5 | PSYGENET | |
Tgene | C1269683 | Major Depressive Disorder | 5 | CTD_human;PSYGENET | |
Tgene | C0009171 | Cocaine Abuse | 3 | CTD_human | |
Tgene | C0236736 | Cocaine-Related Disorders | 3 | CTD_human | |
Tgene | C0600427 | Cocaine Dependence | 3 | CTD_human | |
Tgene | C0020429 | Hyperalgesia | 2 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 2 | CTD_human | |
Tgene | C0085762 | Alcohol abuse | 2 | CTD_human;PSYGENET | |
Tgene | C0458247 | Allodynia | 2 | CTD_human | |
Tgene | C0751211 | Hyperalgesia, Primary | 2 | CTD_human | |
Tgene | C0751212 | Hyperalgesia, Secondary | 2 | CTD_human | |
Tgene | C0751213 | Tactile Allodynia | 2 | CTD_human | |
Tgene | C0751214 | Hyperalgesia, Thermal | 2 | CTD_human | |
Tgene | C0751217 | Hyperkinesia, Generalized | 2 | CTD_human | |
Tgene | C2936719 | Mechanical Allodynia | 2 | CTD_human | |
Tgene | C3887506 | Hyperkinesia | 2 | CTD_human | |
Tgene | C0004352 | Autistic Disorder | 1 | CTD_human | |
Tgene | C0004782 | Basal Ganglia Diseases | 1 | CTD_human | |
Tgene | C0005587 | Depression, Bipolar | 1 | CTD_human | |
Tgene | C0007852 | Cervical Migraine Syndrome | 1 | CTD_human | |
Tgene | C0013384 | Dyskinetic syndrome | 1 | CTD_human | |
Tgene | C0015371 | Extrapyramidal Disorders | 1 | CTD_human | |
Tgene | C0015967 | Fever | 1 | CTD_human | |
Tgene | C0018984 | Hemicrania migraine | 1 | CTD_human | |
Tgene | C0024117 | Chronic Obstructive Airway Disease | 1 | CTD_human | |
Tgene | C0024517 | Major depression, single episode | 1 | PSYGENET | |
Tgene | C0024713 | Manic Disorder | 1 | CTD_human | |
Tgene | C0025517 | Metabolic Diseases | 1 | CTD_human | |
Tgene | C0028754 | Obesity | 1 | CTD_human | |
Tgene | C0028768 | Obsessive-Compulsive Disorder | 1 | CTD_human | |
Tgene | C0033958 | Psychosis, Brief Reactive | 1 | CTD_human | |
Tgene | C0033975 | Psychotic Disorders | 1 | CTD_human | |
Tgene | C0036337 | Schizoaffective Disorder | 1 | CTD_human | |
Tgene | C0036358 | Schizophreniform Disorders | 1 | CTD_human | |
Tgene | C0149931 | Migraine Disorders | 1 | CTD_human | |
Tgene | C0152115 | Lingual-Facial-Buccal Dyskinesia | 1 | CTD_human | |
Tgene | C0221169 | Hemiballismus | 1 | CTD_human | |
Tgene | C0232766 | Asterixis | 1 | CTD_human | |
Tgene | C0270458 | Severe major depression with psychotic features | 1 | PSYGENET | |
Tgene | C0270858 | Abdominal Migraine | 1 | CTD_human | |
Tgene | C0338489 | Status Migrainosus | 1 | CTD_human | |
Tgene | C0338831 | Manic | 1 | CTD_human | |
Tgene | C0427086 | Involuntary Movements | 1 | CTD_human | |
Tgene | C0454606 | Oral Dyskinesia | 1 | CTD_human | |
Tgene | C0521664 | Acute Confusional Migraine | 1 | CTD_human | |
Tgene | C0700438 | Sick Headaches | 1 | CTD_human | |
Tgene | C0750951 | Lenticulostriate Disorders | 1 | CTD_human | |
Tgene | C0752196 | Ballismus | 1 | CTD_human | |
Tgene | C1527303 | Chronic Airflow Obstruction | 1 | CTD_human |